Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Global Clinical Workflow Solutions Market Analysis Report 2023: A $24.37 Billion Market by 2030 - AI-Assisted Technology Redefining Healthcare with Error Reduction and Decision Support
Company Logo
Company Logo

Global Clinical Workflow Solutions Market

Global Clinical Workflow Solutions Market
Global Clinical Workflow Solutions Market

Dublin, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The "Clinical Workflow Solutions Market Size, Share & Trends Analysis Report By Type (Data Integration Solutions, Workflow Automation Solutions), By End-use (Hospitals, Ambulatory Care Centers), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

The global clinical workflow solutions market size is estimated to reach USD 24.37 billion by 2030, growing at a CAGR of 12.4%

Clinical process automation is on the rise, with a particularly significant impact seen in developed nations like the U.S. Healthcare is witnessing a transformation propelled by initiatives from both public and commercial organizations.

The demand for scalable healthcare systems is further fueled by the necessity to provide clinicians with remote access to critical data insights. Notably, a survey conducted in March 2023 revealed that over 30% of U.S. hospitals, health systems, and transplant centers have already integrated Clinical Workflow Automation (CWA), and this figure is expected to soar to 61% by 2024.

Moreover, almost half of the organizations implementing CWA aim to extend its application to more clinical settings by 2023. This growth trajectory is driven by the misconception among some respondents that their existing Electronic Health Record (EHR) vendors or basic software programs can deliver CWA functionalities. The adoption of CWA is poised to continue expanding as public awareness and understanding of its capabilities increase.

The healthcare sector, especially healthcare providers, has encountered significant challenges during the COVID-19 pandemic, underlining the critical need for remote access to data insights and efficient clinical processes. Consequently, companies are expanding their horizons and pursuing strategic acquisitions to diversify and align their product portfolios.

For example, Fortive's USD 1.4 billion acquisition of Provation in December 2021 enhances its position in vital workflow solutions for hospitals and ambulatory surgical centers, aligning with the Advanced Healthcare Solutions (AHS) segment.

To maintain a competitive edge, market players are actively investing in the development and introduction of innovative products. bioMerieux's launch of MAESTRIA in February 2023 is a notable example. MAESTRIA, a state-of-the-art middleware solution for clinical microbiology laboratories, streamlines daily operations and enhances operational efficiency by managing workflow tasks.